Brian Bumpus
Associate Director
Expertise:
With more than 20 years of experience, Brian is a seasoned pharmaceutical industry contracting executive with broad experience in government pricing, and commercial contract management and compliance matters. His specialized expertise is in the Medicaid Drug Rebate Program, the Federal Supply Schedule (Veteran Affairs, Department of Defense, Indian Health Services, and PHS 340B agreements) and Class of Trade management. Brian also brings experience in assisting complex contracting and government compliance challenges for pharmaceutical, medical device and medical laboratory companies. Brian holds a bachelor’s degree in biology from Luther College and is a certified fraud examiner.
Articles by Brian Bumpus
Webinar: Drug Pricing and Reporting Regulatory Updates Part 2
In Part 2 of our Drug Pricing and Reporting Regulatory Updates webinar, EVERSANA revenue experts Michael Kurland and Brian Bumpus take a look at the Final Rule, which was released by the Centers for Medicare and Medicaid Services in December 2020. Legislative actions related to the rule will go into effect through 2023. This webinar […]
Drug Pricing And Drug Price Reporting Regulatory Update
As the new president and Congress begin their terms, EVERSANA would like to provide an update on recent legislative and regulatory actions that affect drug pricing and price reporting. The Centers for Medicare and Medicaid Services (CMS) issued this interim final rule on November 20, 2020 (85 Fed Reg 76180-76259), requiring a revised calculation of […]
CMS Proposed Medicaid Rule: Best Price Impacts of Value-Based Purchasing, Co-Pay Assistance Programs, and More
On June 17, 2020, the Centers for Medicare and Medicaid Services (CMS) published a proposed rule outlining nine specific changes to Medicaid regulations. Five of these directly affect manufacturers through changes in administration of the Medicaid Drug Rebate Program (MDRP): Value-based Purchasing Arrangements Line Extensions Patient Assistance Programs MDRP Definition Clarifications Authorized Generics Download EVERSANA’s […]